Edmond P H Choi1, Carlos K H Wong2, James H L Tsu3, W Y Chin2, Kenny Kung2, Charles K W Wong3, M K Yiu3. 1. School of Nursing, The University of Hong Kong, 4/F, William M.W. Mong Block, 21 Sassoon Road, Pokfulam, Hong Kong. h0714919@connect.hku.hk. 2. Department of Family Medicine and Primary Care, The University of Hong Kong, Ap Lei Chau, Hong Kong. 3. Division of Urology, Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong.
Abstract
PURPOSE: The purpose of this study was to compare the health-related quality of life (HRQOL) of Chinese patients with prostate cancer against the general population and patients with colorectal cancer, breast cancer, nasopharyngeal cancer, and leukemia. METHODS: Chinese male patients (n = 291) with a confirmed diagnosis of prostate cancer were recruited from a urological specialist outpatient clinic in Hong Kong. HRQOL was measured by a condition-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P) and a generic Chinese (HK) SF-12 Health Survey Version 2 (SF-12v2) questionnaire. Mean HRQOL scores of condition-specific and generic questionnaires were compared to available scores derived from other cancers and age-matched male general population, respectively. RESULTS: Chinese patients with prostate cancer had lower general health and vitality domains and lower mental component summary scores than the age-matched Hong Kong normative population. Patients with prostate cancer reported better condition-specific HRQOL (physical well-being, emotional well-being and function well-being) when compared to general cancer population, patients with breast cancer, colorectal cancer, nasopharyngeal cancer, and leukemia in Hong Kong. CONCLUSIONS: Patients with prostate cancer substantially perceived their HRQOL to be better, compared to patients with other cancers, with overall health, energy, and mental health below of Hong Kong general population. Interventions should target at these domains in order to improve the HRQOL of patients with prostate cancer. It is reassuring to find that prostate cancer had less negative impact on HRQOL than other cancer types did.
PURPOSE: The purpose of this study was to compare the health-related quality of life (HRQOL) of Chinese patients with prostate cancer against the general population and patients with colorectal cancer, breast cancer, nasopharyngeal cancer, and leukemia. METHODS: Chinese male patients (n = 291) with a confirmed diagnosis of prostate cancer were recruited from a urological specialist outpatient clinic in Hong Kong. HRQOL was measured by a condition-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P) and a generic Chinese (HK) SF-12 Health Survey Version 2 (SF-12v2) questionnaire. Mean HRQOL scores of condition-specific and generic questionnaires were compared to available scores derived from other cancers and age-matched male general population, respectively. RESULTS: Chinese patients with prostate cancer had lower general health and vitality domains and lower mental component summary scores than the age-matched Hong Kong normative population. Patients with prostate cancer reported better condition-specific HRQOL (physical well-being, emotional well-being and function well-being) when compared to general cancer population, patients with breast cancer, colorectal cancer, nasopharyngeal cancer, and leukemia in Hong Kong. CONCLUSIONS:Patients with prostate cancer substantially perceived their HRQOL to be better, compared to patients with other cancers, with overall health, energy, and mental health below of Hong Kong general population. Interventions should target at these domains in order to improve the HRQOL of patients with prostate cancer. It is reassuring to find that prostate cancer had less negative impact on HRQOL than other cancer types did.
Entities:
Keywords:
Chinese; Patient-reported outcome; Prostate cancer; Quality of life; Urology
Authors: Carlos K H Wong; Edmond P H Choi; James H L Tsu; Brian S H Ho; Ada T L Ng; W Y Chin; M K Yiu Journal: Qual Life Res Date: 2015-04-16 Impact factor: 4.147
Authors: Jakob B Bjorner; Gene V Wallenstein; Marie C Martin; Peggy Lin; Bonnie Blaisdell-Gross; Catherine Tak Piech; Samir H Mody Journal: Curr Med Res Opin Date: 2007-04 Impact factor: 2.580
Authors: Carlos K Wong; Cindy L Lam; Wai-Lun Law; Jensen T Poon; Dora L Kwong; Janice Tsang; Yuk-Fai Wan Journal: J Clin Epidemiol Date: 2013-02-08 Impact factor: 6.437
Authors: Christine Bouchardy; Gerald Fioretta; Elisabetta Rapiti; Helena Maria Verkooijen; Charles Henry Rapin; France Schmidlin; Raymond Miralbell; Roberto Zanetti Journal: Int J Cancer Date: 2008-07-15 Impact factor: 7.396
Authors: Edmond P H Choi; Carlos K H Wong; Eric Y F Wan; James H L Tsu; W Y Chin; Kenny Kung; M K Yiu Journal: Qual Life Res Date: 2016-02-23 Impact factor: 4.147
Authors: Eric Yuk Fai Wan; Edmond Pui Hang Choi; Esther Yee Tak Yu; Weng Yee Chin; Colman Siu Cheung Fung; Anca Ka Chun Chan; Cindy Lo Kuen Lam Journal: Qual Life Res Date: 2018-06-13 Impact factor: 4.147
Authors: Qingmei Huang; Ping Jiang; Zijun Zhang; Jie Luo; Yun Dai; Li Zheng; Wei Wang Journal: Support Care Cancer Date: 2017-06-22 Impact factor: 3.603
Authors: Ali Gholami; Shabnam Nadjafi; Farhad Moradpour; Zahra Mousavi Jahromi; Ali Montazeri; Mohamad-Reza Vaez-Mahdavi; Ali Asghar Haeri Mehrizi; Abbas Abbasi-Ghahramanloo; Sare Hatamian; Masoudreza Sohrabi; Mohsen Asadi-Lari Journal: Med J Islam Repub Iran Date: 2018-10-18
Authors: Julie Y Chen; Edmond P H Choi; Eric Y F Wan; Anca K C Chan; Joyce P Y Tsang; Karina H Y Chan; W K Lo; S L Lui; W L Chu; Cindy L K Lam Journal: PLoS One Date: 2016-05-05 Impact factor: 3.240
Authors: Edmond Pui Hang Choi; Qiuyan Liao; Inda Soong; Karen Kar Loen Chan; Conrad C Y Lee; Alice Ng; Wing Kin Sze; Janice Wing Hang Tsang; Victor Ho Fun Lee; Wendy Wing Tak Lam Journal: Health Qual Life Outcomes Date: 2020-02-17 Impact factor: 3.186